An estimated 800 million people's food and income are threatened by rapidly spreading cassava diseases. But in good news for cassava breeders and farmers, breakthrough research has established the pathogens and the first diagnostic tests for two diseases: Cassava Frogskin Disease and Cassava Witches’ Broom Disease. This achievement can revolutionize cassava disease management across Latin America and the Caribbean as well as Southeast Asia, where farmers and researchers have been working side-by-side to fight the spread of these diseases for decades.

In an interdisciplinary and transdisciplinary study, an international team led by the University of Vienna and the Danish Technical University/Umea University examined the social risks for Arctic regions associated with thawing permafrost. They identified five key risks related to infrastructure, transport and supply, water quality, food security and health. The scientists found that the thawing permafrost posed an increased risk of exposure to infectious diseases and release of contaminants, and interruptions of supply routes. The study has been published in the renowned journal Communications Earth and Environment. 

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

The FDA ban on Red Dye 3, cancer survivorship and what it  means to live with cancer, global trends in lung cancer deaths, researching gynecologic cancer disparities in women of Arican ancestry and more are included in Sylvester Cancer's January tip sheet.

Nipah virus (NiV) is a zoonotic paramyxovirus that has recently emerged as a crucial public health issue. It can elicit severe encephalitis and respiratory diseases in animals and humans, leading to fatal outcomes, exhibiting a wide range of host species tropism, and directly transmitting from animals to humans or through an intermediate host. Human-to-human transmission associated with recurrent NiV outbreaks is a potential global health threat. Currently, the lack of effective therapeutics or licensed vaccines for NiV necessitates the primary utilization of supportive care. In this review, we summarize current knowledge of the various aspects of the NiV, including therapeutics, vaccines, and its biological characteristics, epidemiology, pathogenesis, and clinical features. The objective is to provide valuable information from scientific and clinical research and facilitate the formulation of strategies for preventing and controlling the NiV.